Cargando

Slzii.com Buscar

Buscar (Noticias)
/C O R R E C T I O N -- Johnson & Johnson/
(MENAFN - PR Newswire)In the news release, Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE), issued 03-Mar-2026 by Johnson & ...
2026-03-03 19:45:55

¿Qué estás haciendo?
0.04209303855896


Noticias
Noticias

Últimas noticias y titulares
(MENAFN - PR Newswire)In the news release, Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus e...
Noticias